Fmoc-D-Propargylglycine

Fmoc-D-Propargylglycine is a D-configured propargyl-substituted glycine derivative bearing an Fmoc-protecting group on the amino functionality and a terminal alkyne on the side chain. The stereogenic center at the alpha carbon is fixed as the D-enantiomer, enabling stereochemically defined incorporation into peptide sequences and chiral synthetic routes. The molecule combines a protected amine (Fmoc) with an orthogonally reactive propargyl group, supporting both standard peptide coupling chemistry and downstream click-type functionalization. The presence of the terminal alkyne and the stable Fmoc carbamate makes it suitable as a peptide building block and as a chiral intermediate for functionalized amino acid derivative synthesis.

1. Peptide Synthesis

Fmoc-D-Propargylglycine is employed as a protected amino acid building block in solid-phase peptide synthesis and solution-phase peptide assembly where stereochemical fidelity of the D-amino acid is required. The Fmoc-protected amine participates in routine peptide coupling after Fmoc removal, while the side-chain terminal alkyne remains chemically addressable for post-coupling derivatization. The propargyl substituent can be used to introduce a defined handle for subsequent conjugation or for building peptidomimetic motifs that depend on alkyne positioning. The resulting alkyne-bearing peptide intermediates support sequential functionalization strategies that connect amino acid sequence design with modular chemical modification.

2. Bioconjugation Chemistry

Fmoc-D-Propargylglycine is suitable for chemical biology workflows that rely on orthogonal functional group chemistry, particularly terminal alkyne-based conjugation. The propargyl side chain can undergo bioorthogonal coupling reactions such as azide-alkyne cycloaddition to generate stable triazole linkages for labeling, target engagement probes, or immobilized biomolecule constructs. The D-stereochemistry can be used to tune peptide conformation and proteolytic stability in conjugated biomolecular scaffolds while maintaining a reactive alkyne handle. The Fmoc-protected amino acid format enables controlled incorporation into peptide carriers and downstream generation of defined conjugation-ready intermediates.

3. Peptidomimetics And SAR

Fmoc-D-Propargylglycine is applied in medicinal chemistry and structure-activity relationship studies where D-amino acid incorporation and side-chain functionalization are used to modulate molecular recognition. The terminal alkyne can serve as a functional group for installing linkers, pharmacophore fragments, or reporter tags without altering the peptide backbone connectivity. The Fmoc-protected amino acid derivative supports iterative synthesis of analog series, enabling systematic variation of stereochemistry at the alpha center while keeping the reactive handle constant. The resulting alkyne-functionalized peptide analogs can be further transformed into diverse peptidomimetic architectures for SAR mapping and fragment-based scaffold exploration.

4. Chiral Building Block Synthesis

Fmoc-D-Propargylglycine is utilized as a chiral amino acid intermediate for stereoselective synthetic planning that requires a defined D-configuration at the alpha carbon. The Fmoc carbamate provides a robust protecting-group strategy compatible with multiple synthetic operations, while the terminal alkyne enables selective functional transformations after deprotection or incorporation into larger frameworks. The propargyl group can be leveraged to access additional chiral derivatives through controlled derivatization, including linker installation or conversion into other alkyne-derived motifs. The compound's dual role as a protected amino acid and an alkyne-bearing chiral intermediate supports downstream construction of functionalized amino acid derivatives and chiral building blocks used in fine chemical synthesis.

5. Process Chemistry Intermediate

Fmoc-D-Propargylglycine is appropriate for industrial and process-oriented synthesis of alkyne-functional amino acid derivatives and peptide intermediates where protected amino acid handling is central. The Fmoc-protecting group enables predictable protection/deprotection cycles that integrate with scalable peptide coupling workflows, while the terminal alkyne provides a downstream conversion point for manufacturing routes that require late-stage functionalization. The stable combination of protected amine and reactive side-chain supports manufacturing designs that minimize exposure of the terminal alkyne during earlier steps and reserve functional group transformations for later stages. The resulting intermediates can feed into specialty chemical production of alkyne-tagged peptides, conjugation-ready building blocks, and processable reagents for chemical manufacturing programs.

1. High fat diet and GLP-1 drugs induce pancreatic injury in mice

2. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

3. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

5. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I